University of Pennsylvania School of Medicine Department of Radiology

Slides:



Advertisements
Similar presentations
Bioinformatics for Metabolomics and Fluxomics E’ ? ? ? ? ? ? A?C? E ABCD E v1v1 v2v2 v3v3 v4v4 v5v5 v6v6 v7v7 ABCD E RL 1; metabolite identification RL.
Advertisements

Targeting the Cell Cycle in Lymphoma Therapy Selina Chen-Kiang Weill Cornell Medical College.
The Effects of an Increasing Dilution Rate on Biomass Growth and Nitrogen Metabolism of Saccharomyces cerevisiae Kasey O’Connor Ashley Rhoades Department.
Tyrosine kinase signalling (review) TGF signalling Notch signalling.

Malignant Melanoma and CDKN2A
THE IN VITRO EFFECTS OF BRYOSTATIN-1 IN CONJUNCTION WITH TEMOZOLOMIDE ON U87MG HUMAN GLIOBLASTOMA MULTIFORME CELLS Stefani Fults, BA & Jeffrey P. Thompson,
Metabolic pathway alteration, regulation and control (5) -- Simulation of metabolic network Xi Wang 02/07/2013 Spring 2013 BsysE 595 Biosystems Engineering.
Introduction: Acknowledgments Thanks to Department of Biotechnology (DBT), the Indo-US Science and Technology Forum (IUSSTF), University of Wisconsin-Madison.
While gene expression data is widely available describing mRNA levels in different cancer cells lines, the molecular regulatory mechanisms responsible.
The Bruton’s Tyrosine Kinase Inhibitor PCI is Highly Active as Single-Agent Therapy in Previously-Treated Mantle Cell Lymphoma (MCL): Preliminary.
Date of download: 5/28/2016 Copyright © 2016 SPIE. All rights reserved. Organization of metabolism. The living organism is represented as a hierarchical.
Relationship Between STAT3 Inhibition and the Presence of p53 on Cyclin D1 Gene Expression in Human Breast Cancer Cell Lines Introduction STAT3 and p53.
Can Drug Discovery Research be Done At An Undergraduate Institution?
Ganesan Raja, Siwon Kim, Dahye Yoon, Heonho Lee and Suhkmann Kim*
“Investigation of the role of thrombin in insulin resistance”
Interleukin-1β induces cyclooxygenase-2 expression and promotes the invasive ability of human mesenchymal stem cells derived from ovarian endometrioma 
by Pascal Gelebart, Mona Anand, Hanan Armanious, Anthea C
Figure 1 Current treatments for PNETs
BTK Inhibitors in Relapsed/Refractory Mantle Cell Lymphoma
Volume 15, Issue 2, Pages (February 2012)
Volume 21, Issue 7, Pages (July 2014)
c-Kit as a Novel Potential Therapeutic Target in Colorectal Cancer
Figure 2 Therapeutic targeting of the PI3K/AKT/mTOR pathway
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Alyssa Gomes and Tessa Morris
Volume 138, Issue 4, Pages (August 2009)
Lecture 7: Biological Network Crosstalk Y. Z
Nat. Rev. Urol. doi: /nrurol
Figure 1 Therapeutic targeting of the B-cell receptor (BCR)
Regulation of gene expression by FACT.
Miquel Duran-Frigola, Roberto Mosca, Patrick Aloy  Chemistry & Biology 
Glutamine mediates oncogenic transformations in high‐invasive cells by regulating STAT3 activity Comparison of OVCAR3 invasive capacity in Gln depleted.
Volume 17, Issue 3, Pages (March 2013)
ASSIGNMENT 10 Use the UP and DOWN tags as provided and query the LINCS. These are the KRAS-DEP (UP) and KRAS-IND (DOWN) gene signatures from Singh et al.
Multiple Acquired Resistance Mutations of the ALK Tyrosine Kinase Domain after Sequential Use of ALK Inhibitors  Hsin-Yi Wang, MD  Journal of Thoracic.
Inhibition of mammalian target of rapamycin: Two goals with one shot?
BRC Science Highlight Developmental regulation of processes, pathways, and genes that affect stem growth and composition in sorghum Objective Obtain information.
Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphoma by Hanna Karvonen, David Chiron, Wilhelmiina Niininen,
Volume 60, Issue 2, Pages (October 2015)
MITF upregulation leads to Hsp90i resistance
Lea Goentoro, Marc W. Kirschner  Molecular Cell 
Volume 26, Issue 6, Pages e3 (December 2017)
Volume 20, Issue 4, Pages (October 2014)
Volume 169, Issue 3, Pages e8 (April 2017)
Meta-analysis of the Listeriomics transcriptomic data sets.
Identification of de novo synthesized UPF1 target proteins.
Altered pathways in prostate cancer.
Lynnea R. Waters, Fasih M. Ahsan, Dane M
Loss of Keap1 contributes to LSCC pathogenesis by activating the NRF2–ROS pathway. Loss of Keap1 contributes to LSCC pathogenesis by activating the NRF2–ROS.
CDK4/6 knockdown causes upregulation of MYC, GLS1, and P‐mTOR and downregulation of HIF‐1α CDK4/6 knockdown causes upregulation of MYC, GLS1, and P‐mTOR.
Glutamine addiction and cancer invasiveness are positively correlated in ovarian cancer cells (OVCA) Gln deprivation effect on proliferation rate of a.
Volume 15, Issue 2, Pages (April 2016)
Bcl-2 and bcl-xL Antisense Oligonucleotides Induce Apoptosis in Melanoma Cells of Different Clinical Stages  Robert A. Olie, Christoph Hafner, Renzo Küttel,
Fig. 4 Lkb1 loss in sciatic nerves triggers a metabolic reprogramming.
Volume 2, Issue 1, Pages 9-19 (July 2005)
Derivation of ImSig. Derivation of ImSig. A, An example of a correlation network generated from a tissue data set where nodes represent unique genes and.
Evaluation of top candidate clones for selective killing in bispecific antibody format. Evaluation of top candidate clones for selective killing in bispecific.
Identification of NSC as a FADD-kinase inhibitor.
Suppression of melanoma cell proliferation in response to kinase inhibitors. Suppression of melanoma cell proliferation in response to kinase inhibitors.
In vitro invasion assays were done in the Chemicon invasion chamber containing extracellular matrix. In vitro invasion assays were done in the Chemicon.
Protein expression profile in a dasatinib-resistant cell line.
The effect of IAA and glycyrrhizin (Gc) on growth of human melanoma cells. The effect of IAA and glycyrrhizin (Gc) on growth of human melanoma cells. A,
Discovery of Gö6976-related potent reversible EGFR T790M inhibitors.
The effect of different concentrations of WMC-79 and time of exposure on the growth of HCT-116 cells. The effect of different concentrations of WMC-79.
Identification of compounds that enhance TMZ cytotoxicity in melanoma cells by screening the Spectrum Collection library. Identification of compounds that.
HOXA11-AS acts as a ceRNA for miR-1297.
IL-1β expression is increased in MM cell lines by the co-culture with platelets in vitro. IL-1β expression is increased in MM cell lines by the co-culture.
One potential implementation for the use of outlier kinase profiling and targeting for clinical management of pancreatic cancer in a precision medicine.
Differences in tumour cell metabolism and cytokine/chemokine expression among the three HCC subtypes. Differences in tumour cell metabolism and cytokine/chemokine.
Presentation transcript:

University of Pennsylvania School of Medicine Department of Radiology Metabolic flux analysis of mantle cell lymphoma cells upon Bruton tyrosine kinase inhibition Seung-Cheol Lee, PhD University of Pennsylvania School of Medicine Department of Radiology

13C Metabolic Flux Analysis (MFA) Chance (1984) – heart, NMR Malloy (1988) – heart, NMR Mason, Gruetter, Rothman (1995) – brain, NMR Wiechert (1997) – microorganism, NMR, MS Stephanopoulos (2009) – cancer cells, MS Shestov (2016) – cancer cells, NMR

Melanoma cells, Dynamic MFA Shestov, Mancuso and Lee et al., Journal of Biological Chemistry 2016

Application of MFA to lymphoma cells and BTK inhibitor Bruton tyrosine kinase (BTK) inhibitor Mantle cell lymphoma (MCL) Cytostatic drug Find which pathways are affected by the inhibitor and determine metabolic pathways to be further targeted

Differential response of MCL cells to BTK inhibitor Jeko RL

1H NMR 48 hr treatment with 500 nM ibrutnib p=0.0003 p=0.01 p=0.003

Metabolite 13C enrichment determination (Proton Observe Carbon Edited NMR) 2.4 2.2 2.0 1.8 1.6 1.4 1.2 PPM 2.6 12C Glu 12C Ala 12C Lac 13C Glu 13C Ala 13C Lac RL cells Jeko cells p=0.01 p=0.02 48 hr treatment + incubation with [1,6]glucose for 8 hr

Glutamate mulitiplet ratio determination 13C NMR 34.8 34.6 34.4 34.2 34.0 33.8 PPM 4s 4d34 28.2 28.0 27.8 27.6 3s 3d43 Glu4 Glu3 RL cells Jeko cells p=0.03

Mass balance equations Chemical mass balance 13C isotope balance

Metabolic network

Determined metabolic fluxes

Correlation with RNA-seq analysis * data not shown due to very low gene expression of this LDH isoform in JeKo-1 cells

Treatment of MCL cells with a glutaminase inhibitor Cell growth (MTT assay)

Summary We have determined various metabolic fluxes of MCL cells (RL and Jeko) upon perturbation with BTK inhibition by using 13C NMR metabolic flux analysis. Glutaminolytic pathway was found to be unaffected by BTK inhibition in Jeko cells . Treatment of Jeko cells with a glutaminase inhibitor resulted in profound growth inhibition.

Acknowledgement NIH R01-CA172820 R01-CA129544